Overall, the findings suggest that 4% tetrasodium EDTA may offer a promising strategy to reduce CVAD-related complications in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results